Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTN7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,527
Award facts
- Contract value 100% obligated
- $27,526.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,526.87 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets (30-count units) on January 11, 2026, with completion scheduled for January 12, 2026. This firm fixed-price, non-set-aside delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The company demonstrates significant capacity to fulfill government pharmaceutical requirements through its competitive position on the DLA Troop Support Medical IDC, which enables delivery of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and other federal medical institutions worldwide. This delivery order for RINVOQ ER, a rheumatoid arthritis medication, exemplifies the company's role in supplying critical pharmaceutical products to support Defense Health Agency operations and broader federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FXTN7?
SPE2DR26FXTN7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 11, 2026.
How much is contract SPE2DR26FXTN7 worth?
The government has obligated $27,527 on SPE2DR26FXTN7.
Is contract SPE2DR26FXTN7 an order under another contract?
Yes. SPE2DR26FXTN7 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTN7 competed?
The extent of competition for SPE2DR26FXTN7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award